BMJ 1995;311:844-846 (30 September)

Papers

Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials

Rebecca L Aspinall, senior house officer,a Neville W Goodman, consultant senior lecturer a

a University Department of Anaesthesia, Medical School Unit, Southmead Hospital, Bristol BS10 5NB

Correspondence to: Dr Goodman.

Abstract

Objective: To determine how many patients were deprived of treatment by being given placebo as comparator in trials of ondansetron for postoperative nausea and vomiting.
Design: Review of published trials of ondansetron during 1991 to July 1994.
Setting: Medline search in a university department of anaesthesia.
Subjects: 8806 patients who had been included in 18 indexed placebo controlled trials of ondansetron as prophylaxis against or treatment of postoperative nausea and vomiting.
Results: Five studies (1236 patients) had been published by July 1992. All were placebo controlled trials. By July 1994, 8806 patients had been included in 18 indexed placebo controlled studies of prophylaxis or treatment. Only 462 patients had been in studies that compared ondansetron with other drugs, and there were no indexed comparative trials of treatment of nausea and vomiting. Roughly 2180 patients had been given placebo as prophylaxis and 440 had been given placebo when already experiencing postoperative nausea or vomiting.
Conclusions: Around 2620 patients in the reviewed studies were denied existing drugs, which, though not completely effective or without side effects, do bring some relief from postoperative nausea and vomiting. Drug regulatory bodies should collaborate with drug companies to ensure better comparison of new with established drugs. This would avoid placebos being given to more than the fewest patients necessary to confirm effect and would allow doctors to be informed more quickly about relative efficacies.

Key messages

  • Key messages

  • Placebo controlled trials may be unethical if active drugs are available

  • Drug regulations should be altered to make comparative data mandatory for licensing

  • Drug research should be funded in parallel by the companies and the NHS once drugs are proved safe and effective


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Vandenbroucke, J. P., Elm, E. v., Altman, D. G., Gotzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., for the STROBE initiative, (2007). Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration. ANN INTERN MED 147: W-163-W-194 [Abstract] [Full text]  
  • White, H., Black, R. J., Jones, M., Mar Fan, G. C. (2007). Randomized comparison of two anti-emetic strategies in high-risk patients undergoing day-case gynaecological surgery. Br J Anaesth 98: 470-476 [Abstract] [Full text]  
  • Rusch, D., Eberhart, L., Biedler, A., Dethling, J., Apfel, C. C. (2005). Prospective application of a simplified risk score to prevent postoperative nausea and vomiting: [L'application prospective d'un score de risque simplifie pour prevenir les nausees et les vomissements postoperatoires]. Canadian J. Anesthesia 52: 478-484 [Abstract] [Full text]  
  • Pierre, S., Corno, G., Benais, H., Apfel, C. C. (2004). A risk score-dependent antiemetic approach effectively reduces postoperative nausea and vomiting - a continuous quality improvement initiative: [Un traitement antiemetique relie au score de risque reduit efficacement les nausees et les vomissements postoperatoires - une initiative d'amelioration continue de la qualite]. Canadian J. Anesthesia 51: 320-325 [Abstract] [Full text]  
  • von Elm, E., Poglia, G., Walder, B., Tramer, M. R. (2004). Different Patterns of Duplicate Publication: An Analysis of Articles Used in Systematic Reviews. JAMA 291: 974-980 [Abstract] [Full text]  
  • Fujii, Y., Tanaka, H., Ito, M. (2001). Ramosetron compared with granisetron for the prevention of vomiting following strabismus surgery in children. Br. J. Ophthalmol. 85: 670-672 [Abstract] [Full text]  
  • Fujii, Y., Tanaka, H., Kobayashi, N. (2001). Prevention of Postoperative Nausea and Vomiting With Antiemetics in Patients Undergoing Middle Ear Surgery: Comparison of a Small Dose of Propofol With Droperidol or Metoclopramide. Arch Otolaryngol Head Neck Surg 127: 25-28 [Abstract] [Full text]  
  • Ahmed, A. B., Hobbs, G. J., Curran, J. P. (2000). Randomized, placebo-controlled trial of combination antiemetic prophylaxis for day-case gynaecological laparoscopic surgery{dagger}. Br J Anaesth 85: 678-682 [Abstract] [Full text]  
  • Temple, R., Ellenberg, S. S. (2000). Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific Issues. ANN INTERN MED 133: 455-463 [Abstract] [Full text]  
  • Zarate, E., Watcha, M. F., White, P. F., Klein, K. W., Rego, M. S., Stewart, D. G. (2000). A Comparison of the Costs and Efficacy of Ondansetron Versus Dolasetron for Antiemetic Prophylaxis. Anesth. Analg. 90: 1352-1358 [Abstract] [Full text]  
  • Fujii, Y., Saitoh, Y., Tanaka, H., Toyooka, H. (1999). Comparison of Ramosetron and Granisetron for Preventing Postoperative Nausea and Vomiting After Gynecologic Surgery. Anesth. Analg. 89: 476-476 [Abstract] [Full text]  
  • Fujii, Y., Saitoh, Y., Tanaka, H., Toyooka, H. (1999). Preoperative Oral Antiemetics for Reducing Postoperative Vomiting After Tonsillectomy in Children: Granisetron Versus Perphenazine. Anesth. Analg. 88: 1298-1298 [Abstract] [Full text]  
  • Fujii, Y., Saitoh, Y., Tanaka, H., Toyooka, H. (1999). Granisetron/Dexamethasone Combination for Reducing Nausea and Vomiting During and After Spinal Anesthesia for Cesarean Section. Anesth. Analg. 88: 1346-1346 [Abstract] [Full text]  
  • Goodman, N. W (1999). Trials of postoperative antiemetics need three arms. BMJ 318: 942-942 [Full text]  
  • Tramèr, M. R, Reynolds, D J. M, Moore, R A., McQuay, H. J (1998). When placebo controlled trials are essential and equivalence trials are inadequate. BMJ 317: 875-880 [Full text]  
  • Talbot, D, Reynolds, D J M, Stone, P. G, Blogg, C. E, Rawlins, R., Barton, A. (1997). Local research ethics committees. BMJ 315: 1464-1464 [Full text]  
  • Senn, S. (1997). Are placebo run ins justified?. BMJ 314: 1191-1191 [Full text]  
  • Tramer, M. R, Moore, R A., Reynolds, D J. M, McQuay, H. J (1997). A quantitative systematic review of ondansetron in treatment of established postoperative nausea and vomiting. BMJ 314: 1088-1088 [Abstract] [Full text]  
  • Collier, J. (1995). Confusion over use of placebos in clinical trials. BMJ 311: 821-822 [Full text]  



Student BMJ

Asylum seekers' care

UK medical students have published unreleased government plans to restrict failed asylum seekers' access to medical care

www.student.bmj.com

Listen to the latest BMJ Interview